These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 2889163

  • 21. The binding of 3H-(3-MeHis2) thyrotropin releasing hormone to brain and pituitary membranes of morphine tolerant-dependent and abstinent rats.
    Bhargava HN, Das S, Bansinath M, Prasad R.
    Pharmacol Biochem Behav; 1989 Sep; 34(1):7-12. PubMed ID: 2516632
    [Abstract] [Full Text] [Related]

  • 22. Probes for narcotic receptor mediated phenomena. 17. Synthesis and evaluation of a series of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacet amide (U50,488) related isothiocyanate derivatives as opioid receptor affinity ligands.
    de Costa BR, Rothman RB, Bykov V, Band L, Pert A, Jacobson AE, Rice KC.
    J Med Chem; 1990 Apr; 33(4):1171-6. PubMed ID: 2157008
    [Abstract] [Full Text] [Related]

  • 23. Effects of acute and chronic administration of dizocilpine on the pharmacological responses to U-50,488H and brain and spinal cord kappa-opioid receptors in the rat.
    Bhargava HN, Matwyshyn GA, Gudehithlu KP.
    Pharmacology; 1995 Nov; 51(5):323-30. PubMed ID: 8584584
    [Abstract] [Full Text] [Related]

  • 24. Characterization of kappa opioid binding using dynorphin A1-13 and U69,593 in the rat brain.
    Devlin T, Shoemaker WJ.
    J Pharmacol Exp Ther; 1990 May; 253(2):749-59. PubMed ID: 1971019
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Effects of kappa opiate agonists on palatable food consumption in non-deprived rats, with and without food preloads.
    Jackson A, Cooper SJ.
    Brain Res Bull; 1985 Oct; 15(4):391-6. PubMed ID: 2998563
    [Abstract] [Full Text] [Related]

  • 29. Spinal kappa-opioid receptor-mediated antinociception is stimulus-specific.
    Schmauss C.
    Eur J Pharmacol; 1987 Jun 04; 137(2-3):197-205. PubMed ID: 2886350
    [Abstract] [Full Text] [Related]

  • 30. Characteristics of 3H-tifluadom binding in guinea-pig brain membranes.
    Burkard WP, Müller PM, Flück N.
    J Recept Res; 1984 Jun 04; 4(1-6):165-73. PubMed ID: 6151988
    [Abstract] [Full Text] [Related]

  • 31. Effect of thyrotropin releasing hormone on U-50,488H-induced pharmacological responses in mice.
    Bhargava HN, Thorat SN.
    Brain Res; 1993 Oct 15; 625(1):120-4. PubMed ID: 8242390
    [Abstract] [Full Text] [Related]

  • 32. Serotonergic involvement in the antinociceptive action of and the development of tolerance to the kappa-opioid receptor agonist, U-50, 488H.
    Ho BY, Takemori AE.
    J Pharmacol Exp Ther; 1989 Aug 15; 250(2):508-14. PubMed ID: 2547935
    [Abstract] [Full Text] [Related]

  • 33. Differential affinities of TRH analogs at the mammalian spinal cord TRH receptor: implications for therapy in spinal injuries.
    Sharif NA, To Z, Michel AD, Whiting RL.
    Neurosci Lett; 1989 Sep 25; 104(1-2):183-8. PubMed ID: 2554219
    [Abstract] [Full Text] [Related]

  • 34. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.
    Zhu J, Luo LY, Li JG, Chen C, Liu-Chen LY.
    J Pharmacol Exp Ther; 1997 Aug 25; 282(2):676-84. PubMed ID: 9262330
    [Abstract] [Full Text] [Related]

  • 35. Affinity of drugs and peptides for U-69,593-sensitive and -insensitive kappa opiate binding sites: the U-69,593-insensitive site appears to be the beta endorphin-specific epsilon receptor.
    Nock B, Giordano AL, Cicero TJ, O'Connor LH.
    J Pharmacol Exp Ther; 1990 Aug 25; 254(2):412-9. PubMed ID: 2166790
    [Abstract] [Full Text] [Related]

  • 36. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA, Burks TF.
    J Pharmacol Exp Ther; 1988 Feb 25; 244(2):456-62. PubMed ID: 2831341
    [Abstract] [Full Text] [Related]

  • 37. The effect of the opioid-benzodiazepine, tifluadom, on ingestive behaviors.
    Morley JE, Levine AS, Grace M, Kneip J, Zeugner H.
    Eur J Pharmacol; 1983 Sep 30; 93(3-4):265-9. PubMed ID: 6315453
    [Abstract] [Full Text] [Related]

  • 38. Kappa agonists inhibit gastric emptying but not acid secretion in rhesus monkeys.
    Touzeau PL, Shea-Donohue T.
    J Pharmacol Exp Ther; 1990 Jun 30; 253(3):1010-6. PubMed ID: 1972746
    [Abstract] [Full Text] [Related]

  • 39. Antagonism of kappa opioid mediated effects in the rat by cyclo(Leu-Gly).
    Bhargava HN, Ramarao P.
    Life Sci; 1989 Jun 30; 45(26):2521-8. PubMed ID: 2559273
    [Abstract] [Full Text] [Related]

  • 40. Effect of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord.
    Bhargava HN, Gulati A, Ramarao P.
    J Pharmacol Exp Ther; 1989 Oct 30; 251(1):21-6. PubMed ID: 2552075
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.